Evidence map›Paper›PMID 33078503›Full record

ArticleAddiction biology2021

Chronic opioid exposure differentially modulates oxycodone self-administration in male and female rats.

Maria Mavrikaki, Tania Lintz, Nick Constantino, Sarah Page, Elena Chartoff

Open access · hybridAbstract read
In one paragraph

Article in Addiction biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Impact of Age on Heroin Intravenous Self-Administration in Wistar Rats.bioRxiv : the preprint server for biology · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Maria MavrikakiDepartment of Psychiatry, Harvard Medical School, McLean Hospital, Belmont, Massachusetts, USA.
Tania LintzDepartment of Psychiatry, Harvard Medical School, McLean Hospital, Belmont, Massachusetts, USA.
Nick ConstantinoDepartment of Psychiatry, Harvard Medical School, McLean Hospital, Belmont, Massachusetts, USA.
Sarah PageDepartment of Psychiatry, Harvard Medical School, McLean Hospital, Belmont, Massachusetts, USA.
Elena ChartoffDepartment of Psychiatry, Harvard Medical School, McLean Hospital, Belmont, Massachusetts, USA.ORCID 0000-0002-1657-694X
Harvard University · US

Funding

Neurobiological mechanisms of prescription opioid withdrawalR01DA045000 · NIDA · MCLEAN HOSPITAL · PI CHARTOFF, ELENA H · 2017 to 2021
$2.1M
NIDA NIH HHS R01 DA045000
6 · The paper itself

Abstract

Withdrawal from opioid painkillers can produce short-lived physical symptoms and protracted psychological symptoms including anxiety and depressive-like states that often lead to opioid misuse and opioid use disorder (OUD). Studies testing the hypothesis that opioid withdrawal potentiates the reinforcing effects of opioid self-administration (SA) are largely inconclusive and have focused on males. Although some clinical evidence indicates that women are more likely than men to misuse opioids to self-medicate, preclinical studies in both sexes are lacking. Based on clinical reports, we hypothesized that withdrawal from escalating-dose morphine injections that approximates a prescription painkiller regimen would lead to increased oxycodone SA to a greater extent in female compared to male rats. After escalating-dose morphine (5-30 mg/kg or vehicle, twice/day for 12 days), rats underwent a 2-week abstinence period during which withdrawal signs were measured. The impact of this treatment was assessed on oxycodone SA acquisition, maintenance, dose response, and progressive ratio responding, with additional analyses to compare sexes. We found that both sexes expressed somatic withdrawal, whereas only males demonstrated hyperalgesia in the warm water tail flick assay. During SA acquisition, males with prior morphine exposure took significantly more oxycodone than females. Finally, females with prior morphine exposure demonstrated the lowest motivation to SA oxycodone in the progressive ratio test. Contrary to our initial hypothesis, our findings suggest that prior opioid exposure increases vulnerability to initiate misuse more in males and decreases the reinforcing efficacy of oxycodone in females.

Indexed as

AnimalsFemaleMaleMorphineNarcoticsOpioid-Related DisordersOxycodoneRatsRats, Sprague-DawleyReinforcement, PsychologySelf AdministrationSubstance Withdrawal SyndromeMorphineNarcoticsOxycodonehyperalgesiaintravenous self-administrationopioid use disorderprogressive ratiosex differencessomatic withdrawal

Identifiers

PMID33078503
PMCPMC8129895
OpenAlexW3093227095

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.